Company profile: Prellis Bio
1.1 - Company Overview
Company description
- Provider of holographic two-photon bioprinting and the EXIS™ platform that recreates human immunobiology in vitro using 3D-printed lymph node organoids for antibody discovery, immunogenicity evaluation, and tumor immune systems; services include fully human antibody libraries, vaccine R&D, and large 3D tissue models for disease modeling, ADME/Tox, regenerative medicine, and transplantation into animal models.
Products and services
- Externalized Immune System (EXIS™) Platform: An in vitro platform that recreates human immunobiology using 3D printed LNOs™, enabling antibody discovery, immunogenicity evaluation, and building in vitro tumor immune systems
- Antibody Discovery: A fully human service that uses LNOs™ to produce antibody libraries featuring high-affinity IgG, diverse sequences, and broad epitope recognition
- Bioprinting Technology: A proprietary two-photon 3D printing platform that architects large, complex tumor co-culture systems and biomimetic tissue scaffolds for therapeutic, disease modeling, and regenerative medicine applications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Prellis Bio
Avanti Polar Lipids
HQ: United States
Website
- Description: Provider of phospholipids, sphingolipids, and sterols manufactured by a biotechnology company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Avanti Polar Lipids company profile →
GenVault
HQ: United States
Website
- Description: Provider of sample management solutions for disease diagnosis, research, identification and criminal investigations, offering secure, GxP-compliant biorepository storage for over 60,000,000 samples (ambient to cryogenic), specialized transport and lab relocation with full chain-of-custody and GxP/USDOT compliance, and end-to-end bioinventory support—accession, monitoring, tracking, reporting and disposal—via a secure online portal.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GenVault company profile →
Astero Bio
HQ: United States
Website
- Description: Provider of medical equipment and supplies manufacturing, based in Menlo Park, CA, United States.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Astero Bio company profile →
Ahura Scientific
HQ: United States
Website
- Description: Provider of rugged, ultra-compact, field-enabled optical systems for the immediate identification and authentication of liquid and solid chemical substances, serving homeland security, life sciences, industrial, and medical markets; products include handheld XRF and LIBS analyzers, portable narcotics and chemical identifiers, manufactured in the USA in an ISO 9001-certified facility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ahura Scientific company profile →
Akoya Biosciences
HQ: United States
Website
- Description: Provider of end-to-end spatial biology solutions for high-parameter tissue analysis from biomarker discovery through clinical and translational research, enabling more precise therapies in immuno-oncology and drug development; offerings include PhenoCycler for spatial phenotyping at unprecedented speeds and PhenoImager for comprehensive tissue analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Akoya Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Prellis Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Prellis Bio
2.2 - Growth funds investing in similar companies to Prellis Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Prellis Bio
4.2 - Public trading comparable groups for Prellis Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →